Starbucks (SBUX) stock is moving higher out of the gate Wednesday after the world's largest coffee chain beat top- and bottom-line expectations for its fiscal 2025 first quarter.
In the three months ending December 31, Starbucks said its revenue decreased 0.3% year over year to $9.4 billion, driven by a 4% decline in global comparable-store sales. This marked its fourth consecutive quarter of falling same-store sales.
The company's earnings per share (EPS) fell 23.3% from the year-ago period to 69 cents.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"While we're only one quarter into our turnaround, we're moving quickly to act on the 'Back to Starbucks' efforts and we've seen a positive response," said CEO Brian Niccol in a statement.
"We believe this is the fundamental change in strategy needed to solve our underlying issues, restore confidence in our brand and return the business to sustainable, long-term growth," Niccol added.
The results topped analysts' expectations. Wall Street was anticipating revenue of $9.3 billion and earnings of 67 cents per share, according to CNBC.
Starbucks did not provide guidance for its second quarter or the rest of the fiscal year. In October, the month after Niccol took over as CEO, the company suspended its guidance for 2025 to "allow ample opportunity to complete an assessment of the business and solidify key strategies, while stabilizing and positioning the business for long-term growth."
Is Starbucks stock a buy, sell or hold?
Heading into Wednesday's session, Starbucks shares had generated a 12-month total return (price change plus dividends) of 11%, lagging the S&P 500's 26% gain. And Wall Street has remained on the sidelines when it comes to the consumer discretionary stock.
According to S&P Global Market Intelligence, the average analyst target price for SBUX is $105.54, representing an upside of just over 5% to the large-cap stock's January 28 close. Additionally, the consensus recommendation is Hold.
Financial services firm Wedbush is one of those with a Neutral rating (equivalent to a Hold) on SBUX stock, along with a $100 price target.
"We believe SBUX's current valuation appropriately reflects limited near-term top- and bottom-line visibility, offset by some level of confidence in management's ability to deliver longer-term annual operating margin expansion and EPS growth in line with the brand's equity," says Wedbush analyst Nick Seytan.
Related Content
-
What to Expect in the Rest of This Year's Job Market — and Advice for Job SeekersEspecially in the most competitive fields, job seekers will need to strategize to stand out.
-
Five Tips For Estate Planning in 2025We're almost halfway through the year. Is your estate in order? If not, here are some tips to get it done in 2025.
-
Is Giving Savings Bonds as Gifts Still a Good Idea?Kiplinger editor explores if it's still a good idea to get savings bonds as gifts for children, looking at their returns and usability.
-
Don't Veer Off Course at the First Sign of a Squall in the MarketsWhen markets go nuts and investor sentiment drops, you can keep your sanity by trusting in and sticking with your long-term plan.
-
How Business Owners Can Prepare for a Terminal DiagnosisThe most important thing is readiness, whether the owner faces a life-changing diagnosis or an employee does.
-
Advisers, Take Note: How 2025 Social Security Changes May Impact Your ClientsWhat financial advisers might need to know to help their clients navigate Social Security in 2025.
-
Stock Market Today: Have We Seen the Bottom for Stocks?Solid first-quarter earnings suggest fundamentals remain solid, and recent price action is encouraging too.
-
Social Security Is Taxable, But There Are WorkaroundsIf you're strategic about your retirement account withdrawals, you can potentially minimize the taxes you'll pay on your Social Security benefits.
-
Serious Medical Diagnosis? Four Financial Steps to TakeA serious medical diagnosis calls for updates of your financial, health care and estate plans as well as open conversations with those who'll fulfill your wishes.
-
What Wall Street's CEOs Are Saying About Trump's TariffsWe're in the thick of earnings season and corporate America has plenty to say about the Trump administration's trade policy.
